Viewing Study NCT00038259


Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2026-01-31 @ 11:03 PM
Study NCT ID: NCT00038259
Status: COMPLETED
Last Update Posted: 2021-11-01
First Post: 2002-05-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Interleukin-2 View
None Drug Administration Schedule View
None CD4 Lymphocyte Count View
None Anti-HIV Agents View
None Viral Load View
None Treatment Interruption View
None Treatment Experienced View
None STI View